Atlas Trials

A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi

Clinical trial NCT03939845 · UNKNOWN

Trial details

NCT number
NCT03939845
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Carcinoma, Hepatocellular
Start date
2019-04-23
Primary completion
2021-04-23
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.